☆ 4.7 Meeting Abstract

Mullerian Inhibiting Substance Type 2 Receptor (MISIIR)-Specific CAR T Cells for the Treatment of Ovarian Cancer and Other Gynecologic Malignancies

MOLECULAR THERAPY (2019)

Journal

MOLECULAR THERAPY

Volume 27, Issue 4, Pages 320-320

Publisher

CELL PRESS

Keywords

-

Categories

Biotechnology & Applied Microbiology Genetics & Heredity Medicine, Research & Experimental

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.